Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Assessment of breast cancer response to neoadjuvant chemotherapy: is volumetric MRI a reliable tool?

Lorenzon M, Zuiani C, Londero V, Linda A, Furlan A, Bazzocchi M.

Eur J Radiol. 2009 Jul;71(1):82-8. doi: 10.1016/j.ejrad.2008.03.021. Epub 2008 May 9.

PMID:
18472240
2.

Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.

Takeda K, Kanao S, Okada T, Kataoka M, Ueno T, Toi M, Ishiguro H, Mikami Y, Togashi K.

Eur J Radiol. 2012 Oct;81(10):2627-31. doi: 10.1016/j.ejrad.2011.12.013. Epub 2012 Jan 4.

PMID:
22221829
3.
4.

Response analysis of non-hodgkin lymphoma using magnetic resonance imaging-based volumes.

Rossi M, Dastidar P, Pertovaara H, Järvenpää R, Luukkaala T, Kellokumpu-Lehtinen PL, Rautakunnas S, Heinonen T, Soimakallio S, Eskola H.

J Comput Assist Tomogr. 2009 May-Jun;33(3):466-74. doi: 10.1097/RCT.0b013e31818337d3.

PMID:
19478645
5.

Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.

Chou CP, Wu MT, Chang HT, Lo YS, Pan HB, Degani H, Furman-Haran E.

Acad Radiol. 2007 May;14(5):561-73.

PMID:
17434070
6.

Monitoring neoadjuvant chemotherapy in breast cancer patients: improved MR assessment at 3 T?

Heldahl MG, Lundgren S, Jensen LR, Gribbestad IS, Bathen TF.

J Magn Reson Imaging. 2011 Sep;34(3):547-56. doi: 10.1002/jmri.22642. Epub 2011 Jul 14.

PMID:
21761463
8.

The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study.

Iacconi C, Giannelli M, Marini C, Cilotti A, Moretti M, Viacava P, Picano E, Michelotti A, Caramella D.

Eur Radiol. 2010 Feb;20(2):303-8. doi: 10.1007/s00330-009-1550-z. Epub 2009 Sep 17.

PMID:
19760422
9.

Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.

Jensen LR, Garzon B, Heldahl MG, Bathen TF, Lundgren S, Gribbestad IS.

J Magn Reson Imaging. 2011 Nov;34(5):1099-109. doi: 10.1002/jmri.22726. Epub 2011 Aug 23.

PMID:
22002757
10.

[MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].

Siegmann KC, Müller KT, Vogel U, Krauss K, Claussen CD.

Rofo. 2010 Jun;182(6):493-500. doi: 10.1055/s-0028-1109883. Epub 2009 Dec 1. German.

PMID:
19953430
11.

Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT.

Plathow C, Klopp M, Thieke C, Herth F, Thomas A, Schmaehl A, Zuna I, Kauczor HU.

Eur Radiol. 2008 Aug;18(8):1635-43. doi: 10.1007/s00330-008-0918-9. Epub 2008 Mar 28. Erratum in: Eur Radiol. 2010 Apr;20(4):1023.

PMID:
18369634
12.

Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.

Duarte GM, Cabello C, Torresan RZ, Alvarenga M, Telles GH, Bianchessi ST, Caserta N, Segala SR, de Lima Mda C, Etchebehere EC, Camargo EE, Tinois E.

Ann Surg Oncol. 2007 Oct;14(10):2903-10. Epub 2007 Jul 15.

PMID:
17632758
13.

Volumetric breast density estimation from full-field digital mammograms.

van Engeland S, Snoeren PR, Huisman H, Boetes C, Karssemeijer N.

IEEE Trans Med Imaging. 2006 Mar;25(3):273-82.

PMID:
16524084
14.

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy.

Rieber A, Brambs HJ, Gabelmann A, Heilmann V, Kreienberg R, Kühn T.

Eur Radiol. 2002 Jul;12(7):1711-9. Epub 2002 Feb 14.

PMID:
12111062
15.

Reproducibility and repeatability of volumetric measurements for olfactory bulb volumetry: which method is appropriate? An update using 3 Tesla MRI.

Burmeister HP, Baltzer PA, Möslein C, Bitter T, Gudziol H, Dietzel M, Guntinas-Lichius O, Kaiser WA.

Acad Radiol. 2011 Jul;18(7):842-9. doi: 10.1016/j.acra.2011.02.018.

PMID:
21669350
16.

Three-dimensional magnetic resonance observation of cartilage repair tissue (MOCART) score assessed with an isotropic three-dimensional true fast imaging with steady-state precession sequence at 3.0 Tesla.

Welsch GH, Zak L, Mamisch TC, Resinger C, Marlovits S, Trattnig S.

Invest Radiol. 2009 Sep;44(9):603-12. doi: 10.1097/RLI.0b013e3181b5333c.

PMID:
19692843
17.

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.

Ah-See ML, Makris A, Taylor NJ, Harrison M, Richman PI, Burcombe RJ, Stirling JJ, d'Arcy JA, Collins DJ, Pittam MR, Ravichandran D, Padhani AR.

Clin Cancer Res. 2008 Oct 15;14(20):6580-9. doi: 10.1158/1078-0432.CCR-07-4310.

18.

Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study.

Shah N, Gibbs J, Wolverton D, Cerussi A, Hylton N, Tromberg BJ.

J Biomed Opt. 2005 Sep-Oct;10(5):051503.

PMID:
16292947
19.

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.

Johansen R, Jensen LR, Rydland J, Goa PE, Kvistad KA, Bathen TF, Axelson DE, Lundgren S, Gribbestad IS.

J Magn Reson Imaging. 2009 Jun;29(6):1300-7. doi: 10.1002/jmri.21778.

PMID:
19472387
20.

Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P.

Eur Radiol. 2009 Jul;19(7):1809-16. doi: 10.1007/s00330-009-1327-4. Epub 2009 Feb 24.

PMID:
19238395

Supplemental Content

Support Center